Neonc Technologies Holdings, Inc. (NTHI) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Neonc Technologies reported revenue of $39,990. Net income was -$62.1M (a -155404.4% net margin), or -$3.20 per diluted share. Operating margin was -145637.5%. Operating activities generated -$20.4M of cash, leaving -$20.9M of free cash flow. At fiscal year end, Neonc Technologies held $2.8M in total assets against $20.3M in total liabilities, including $58,729 of cash and equivalents.
Open the full interactive Neonc Technologies financials → Quarterly statements, key ratios, valuation history and price charts.
Neonc Technologies Key Stats
| Share Price | $2.60 |
|---|---|
| Market Cap | $64.0M |
| 52-Week Range | $2.53 – $11.83 |
| Shares Outstanding | 24.7 million (basic, 2026 Q2) |
Neonc Technologies Income Statement
| FY 2025 | |
|---|---|
| Revenue | $39,990 |
| Operating Income | -$58.2M |
| Pre-Tax Income | -$62.1M |
| Net Income | -$62.1M |
| Diluted EPS | -$3.20 |
Neonc Technologies Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | — | — | — | $0 |
| Net Income | -$8.6M | -$9.8M | -$8.8M | -$14.2M |
| Diluted EPS | -$0.45 | -$0.51 | -$0.38 | -$0.58 |
Neonc Technologies Balance Sheet
| FY 2025 | |
|---|---|
| Cash & Equivalents | $58,729 |
| Current Assets | $1.4M |
| Total Assets | $2.8M |
| Current Liabilities | $20.0M |
| Total Liabilities | $20.3M |
| Shareholders' Equity | -$17.5M |
Neonc Technologies Cash Flow Statement
| FY 2025 | |
|---|---|
| Cash From Operations | -$20.4M |
| Cash From Investing | -$500,000 |
| Cash From Financing | $20.9M |
| Free Cash Flow | -$20.9M |
Figures from Neonc Technologies' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Neonc Technologies financials page for every line item.
Neonc Technologies Company Profile
| Ticker | NTHI |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Calabasas, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001979414 |
Frequently Asked Questions
What was Neonc Technologies' revenue in fiscal 2025?
Neonc Technologies (NTHI) reported revenue of $39,990 for fiscal 2025.
What was Neonc Technologies' net income in fiscal 2025?
Neonc Technologies reported net income of -$62.1M for fiscal 2025.
What was Neonc Technologies' earnings per share (EPS) in fiscal 2025?
Neonc Technologies' diluted EPS was -$3.20 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Neonc Technologies generate in fiscal 2025?
Neonc Technologies generated -$20.9M of free cash flow in fiscal 2025.
What was Neonc Technologies' revenue last quarter?
In its most recent reported quarter (2026 Q2), Neonc Technologies reported revenue of $0.
How many shares of Neonc Technologies are outstanding?
Neonc Technologies reported a weighted average of 24.7 million basic shares outstanding in 2026 Q2.
What is Neonc Technologies' market cap?
Based on its latest closing price, Neonc Technologies (NTHI) has a market capitalization of about $64.0M.
When does Neonc Technologies' fiscal year end?
Neonc Technologies' fiscal year end, as registered with the SEC, is December 31.
Where is Neonc Technologies headquartered?
Neonc Technologies lists its business address in Calabasas, California in its SEC filings.